Sweetser MT - Search Results

1

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.

Greenwald MW, Shergy WJ, Kaine JL, Sweetser MT, Gilder K, Linnik MD. Greenwald MW, et al. Among authors: sweetser mt. Arthritis Rheum. 2011 Mar;63(3):622-32. doi: 10.1002/art.30194. Arthritis Rheum. 2011. PMID: 21360491 Free article. Clinical Trial.

2

Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.

Genovese MC, Breedveld FC, Emery P, Cohen S, Keystone E, Matteson EL, Baptiste Y, Chai A, Burke L, Reiss W, Sweetser M, Shaw TM. Genovese MC, et al. Ann Rheum Dis. 2009 Dec;68(12):1894-7. doi: 10.1136/ard.2008.101675. Epub 2009 Jan 20. Ann Rheum Dis. 2009. PMID: 19155233 Free article.

3

Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials.

van Vollenhoven RF, Emery P, Bingham CO 3rd, Keystone EC, Fleischmann R, Furst DE, Macey K, Sweetser M, Kelman A, Rao R. van Vollenhoven RF, et al. J Rheumatol. 2010 Mar;37(3):558-67. doi: 10.3899/jrheum.090856. Epub 2010 Jan 28. J Rheumatol. 2010. PMID: 20110520 Free article.

4

An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy.

Goffe B, Papp K, Gratton D, Krueger GG, Darif M, Lee S, Bozic C, Sweetser MT, Ticho B. Goffe B, et al. Among authors: sweetser mt. Clin Ther. 2005 Dec;27(12):1912-21. doi: 10.1016/j.clinthera.2005.12.007. Clin Ther. 2005. PMID: 16507377

5

Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.

Giovannoni G, Kappos L, Gold R, Khatri BO, Selmaj K, Umans K, Greenberg SJ, Sweetser M, Elkins J, McCroskery P. Giovannoni G, et al. Mult Scler Relat Disord. 2016 Sep;9:36-46. doi: 10.1016/j.msard.2016.05.010. Epub 2016 May 11. Mult Scler Relat Disord. 2016. PMID: 27645341 Free article. Clinical Trial.

6

Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: results from an open-label, multicenter study.

Koo JY, Bagel J, Sweetser MT, Ticho BS. Koo JY, et al. Among authors: sweetser mt. J Drugs Dermatol. 2006 Jul-Aug;5(7):623-8. J Drugs Dermatol. 2006. PMID: 16865867 Clinical Trial.

7

Results of a randomized open-label crossover study of the bioequivalence of subcutaneous versus intramuscular administration of alefacept.

Sweetser MT, Woodworth J, Swan S, Ticho B. Sweetser MT, et al. Dermatol Online J. 2006 Mar 30;12(3):1. Dermatol Online J. 2006. PMID: 16638415 Free article. Clinical Trial.

8

Case reports of PML in patients treated for psoriasis.

Sweetser MT, Dawson KT, Bozic C. Sweetser MT, et al. N Engl J Med. 2013 Sep 12;369(11):1082. doi: 10.1056/NEJMc1307680. N Engl J Med. 2013. PMID: 24040655 No abstract available.

9

Manufacturer's response to case reports of PML.

Sweetser MT, Dawson KT, Bozic C. Sweetser MT, et al. N Engl J Med. 2013 Apr 25;368(17):1659-61. doi: 10.1056/NEJMc1300283. N Engl J Med. 2013. PMID: 23614605 Free article. No abstract available.

10

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.

Giovannoni G, Gold R, Selmaj K, Havrdova E, Montalban X, Radue EW, Stefoski D, McNeill M, Amaravadi L, Sweetser M, Elkins J, O'Neill G; SELECTION Study Investigators. Giovannoni G, et al. Lancet Neurol. 2014 May;13(5):472-81. doi: 10.1016/S1474-4422(14)70039-0. Epub 2014 Mar 19. Lancet Neurol. 2014. PMID: 24656609 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters